1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow AR-12286: new trials by email Literature Review of AR-12286 trials Research Report on AR-12286
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention Rho-Kinase Inhibitor (AR-12286) - Glaucoma | Phase 2 | Unknown | New York Glaucoma Research Institute | 10 | 2014-06-01 | 2015-04-24 |
Glaucoma (1)
New York Glaucoma Research Institute (1)
United States (1)